مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

24
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

11
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

Possible Benefits of Paclitaxel Therapy for COVID-19 (Letter to Editor)

Pages

  91-94

Keywords

Not Registered.

Abstract

 Dear Editor the coronavirus disease 2019 (COVID-19) was reported in Wuhan, China, in late December 2019 and soon became the most serious global health challenge due to the high rate of human-to-human transmission. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a single-stranded RNA virus and belongs to the large Coronaviridae family [1]. The pathogenesis of the COVID-19 still remains poorly understood. Cytokine storm, a hyper-inflammatory state, is considered one of the most important causes of respiratory distress syndrome (ARDS) and death in patients with COVID-19. Clinical studies have reported that there is a strong association between the level of inflammatory cytokines and the severity of the COVID-19 [2]...

Cites

  • No record.
  • References

    Cite

    APA: Copy

    Pashmforosh, Marzieh, Shariati, Saeedeh, Aghaei Nezhad, Hamideh, & HAGHIGHAT, MOJTABA. (2022). Possible Benefits of Paclitaxel Therapy for COVID-19 (Letter to Editor). PHARMACEUTICAL AND BIOMEDICAL RESEARCH, 8(2), 91-94. SID. https://sid.ir/paper/995789/en

    Vancouver: Copy

    Pashmforosh Marzieh, Shariati Saeedeh, Aghaei Nezhad Hamideh, HAGHIGHAT MOJTABA. Possible Benefits of Paclitaxel Therapy for COVID-19 (Letter to Editor). PHARMACEUTICAL AND BIOMEDICAL RESEARCH[Internet]. 2022;8(2):91-94. Available from: https://sid.ir/paper/995789/en

    IEEE: Copy

    Marzieh Pashmforosh, Saeedeh Shariati, Hamideh Aghaei Nezhad, and MOJTABA HAGHIGHAT, “Possible Benefits of Paclitaxel Therapy for COVID-19 (Letter to Editor),” PHARMACEUTICAL AND BIOMEDICAL RESEARCH, vol. 8, no. 2, pp. 91–94, 2022, [Online]. Available: https://sid.ir/paper/995789/en

    Related Journal Papers

  • No record.
  • Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button